[HTML][HTML] Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - nature.com
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
[HTML][HTML] Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - search.ebscohost.com
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.
L Jaki, S Weigang, L Kern, S Kramme, AG Wrobel… - 2023 - crick.figshare.com
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - ideas.repec.org
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - ui.adsabs.harvard.edu
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - econpapers.repec.org
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - europepmc.org
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.
L Jaki, S Weigang, L Kern, S Kramme… - Nature …, 2023 - europepmc.org
Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …
syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat …